Clinical Factors Associated With Long-Term Survival in Metastatic Melanoma Treated With Anti–PD-1 With or Without Ipilimumab
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Factors Associated with Long-Term Survival in Metastatic Melanoma Treated with Anti-PD1 Alone or in Combination with Ipilimumab
Curr Oncol 2022 Oct 14;29(10)7695-7704, S Goutam, I Stukalin, B Ewanchuk, M Sander, PQ Ding, DE Meyers, D Heng, WY Cheung, T ChengFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.